185 related articles for article (PubMed ID: 6105793)
1. Pathophysiologic basis of tardive dyskinesia.
Baldessarini RJ; Tarsy D
Adv Biochem Psychopharmacol; 1980; 24():451-5. PubMed ID: 6105793
[No Abstract] [Full Text] [Related]
2. Tardive dyskinesia: pathophysiology and animal models.
Casey DE
J Clin Psychiatry; 2000; 61 Suppl 4():5-9. PubMed ID: 10739324
[TBL] [Abstract][Full Text] [Related]
3. Dopamine and the pathophysiology of dyskinesias induced by antipsychotic drugs.
Baldessarini RJ; Tarsy D
Annu Rev Neurosci; 1980; 3():23-41. PubMed ID: 6106450
[No Abstract] [Full Text] [Related]
4. The pathophysiologic basis of tardive dyskinesia.
Baldessarini RJ
Psychopharmacol Bull; 1978 Oct; 14(4):79-81. PubMed ID: 30114
[No Abstract] [Full Text] [Related]
5. Neuroleptic-induced tardive dyskinesia.
Jenner P; Marsden CD
Acta Psychiatr Belg; 1987; 87(5):566-98. PubMed ID: 2897761
[TBL] [Abstract][Full Text] [Related]
6. Dogma disputed: is tardive dyskinesia due to postsynaptic dopamine receptor supersensitivity?
Jeste DV; Wyatt RJ
J Clin Psychiatry; 1981 Dec; 42(12):455-7. PubMed ID: 6118358
[TBL] [Abstract][Full Text] [Related]
7. Tardive dyskinesia: a biological appraoch.
Barbaccia ML; Trabucchi M
Prog Clin Biol Res; 1980; 39():181-93. PubMed ID: 6105670
[No Abstract] [Full Text] [Related]
8. [Neuroleptic-induced tardive dyskinesia: recent pathophysiological data, therapeutic trials (author's transl)].
Gaillard-Sizaret C; Gaillard P
Therapie; 1979; 34(5):555-74. PubMed ID: 44767
[No Abstract] [Full Text] [Related]
9. Pathophysiology of antipsychotic drug-induced movement disorders.
Casey DE
J Clin Psychiatry; 2004; 65 Suppl 9():25-8. PubMed ID: 15189109
[TBL] [Abstract][Full Text] [Related]
10. [Current status of our knowledge of the neurotropic side effects of neuroleptic drugs].
Sabbatini F; Pinessi L; Gentile S; De Mattei M; Portaleone P
Minerva Psichiatr; 1983; 24(4):145-53. PubMed ID: 6145083
[No Abstract] [Full Text] [Related]
11. [Neuroleptic parkinsonism and tardive dyskinesia and methods of pharmacologically correcting these pathologic conditions (review)].
Arushanian EB
Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(2):269-77. PubMed ID: 2858951
[No Abstract] [Full Text] [Related]
12. Movement disorders with neuroleptic drug treatment.
Tarsy D
Psychiatr Clin North Am; 1984 Sep; 7(3):453-71. PubMed ID: 6148742
[TBL] [Abstract][Full Text] [Related]
13. The pathophysiologic basis of tardive dyskinesia.
Tarsy D; Baldessarini RJ
Biol Psychiatry; 1977 Jun; 12(3):431-50. PubMed ID: 194633
[TBL] [Abstract][Full Text] [Related]
14. [Tardive dyskinesia].
Kato M; Watanabe K
Ryoikibetsu Shokogun Shirizu; 2003; (38):183-7. PubMed ID: 12876961
[No Abstract] [Full Text] [Related]
15. [Physiopathology and curative treatment of tardive dyskinesia].
Wolf MA; Gautier J
Encephale; 1987; 13(5):301-8. PubMed ID: 2892663
[TBL] [Abstract][Full Text] [Related]
16. Brain iron, dopamine receptor sensitivity, and tardive dyskinesia.
Blinder BJ; Goodman S; Youdim MB
Am J Psychiatry; 1986 Feb; 143(2):277-8. PubMed ID: 2868669
[No Abstract] [Full Text] [Related]
17. Associations among plasma prolactin levels, tardive dyskinesia, and paranoia in treated schizophrenics: relevance to supersensitivity psychosis.
Csernansky JG; Vinogradov S; Prosser E; Kaplan J; Berger PA; Hollister LE
Psychopharmacol Bull; 1986; 22(3):897-9. PubMed ID: 2879311
[No Abstract] [Full Text] [Related]
18. Animal models of tardive dyskinesia--a review.
Kulkarni SK; Naidu PS
Indian J Physiol Pharmacol; 2001 Apr; 45(2):148-60. PubMed ID: 11480221
[TBL] [Abstract][Full Text] [Related]
19. Bereitschaftspotential in tardive dyskinesia.
Adler LE; Pecevich M; Nagamoto H
Mov Disord; 1989; 4(2):105-12. PubMed ID: 2733704
[TBL] [Abstract][Full Text] [Related]
20. Is there a presynaptic tardive dyskinesia?
Bowers MB; Glazer WM
J Clin Psychopharmacol; 1987 Feb; 7(1):57-9. PubMed ID: 2880877
[No Abstract] [Full Text] [Related]
[Next] [New Search]